# Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

> **NCT01434394** · PHASE2,PHASE3 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 243 (actual)

## Conditions studied

- Locally Advanced Malignant Neoplasm
- Oral Cancer
- Oropharyngeal Carcinoma
- Effects of Chemotherapy

## Interventions

- **DRUG:** Neo-adjuvant Erbitux-based chemotherapy

## Key facts

- **NCT ID:** NCT01434394
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-10
- **Final completion:** 2017-02
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2017-08-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434394, "Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01434394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*